NCT06953323 2025-08-13A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid TumorsWigen Biomedicine Technology (Shanghai) Co., Ltd.Phase 1/2 Recruiting86 enrolled